Mahdi Siddique is an associate in the Corporate Practice Group in the London office.
His practice covers mergers and acquisitions, private equity and general corporate advice.
Advising the shareholders of Prescient Healthcare Group, a global product strategy advisory firm serving the biopharmaceutical industry, on the investment in the company by UK private equity firm BDC.
Advising the shareholders of Chemical Watch, a global provider of chemicals management intelligence, on the sale of the company to Enhesa, a Belgian company backed by private equity houses CGE and IGC.
Advising the shareholders of Helios Medical Communications, a global healthcare communications business, on the investment in the company by UK private equity firm NorthEdge.